Search results for "Liver dysfunction"

showing 7 items of 7 documents

Liver Involvement in Hodgkin's Lymphoma: Types of Injuries and Therapeutic Implications

2017

The hepatocytolysis raises questions on following therapeutic conduct when it occurs during chemotherapy for Hodgkin's lymphoma, expression of its liver toxicity. But the onset of primary liver Hodgkin's lymphoma, including the form manifested by acute liver failure, poses even greater problems, as in the case of occurrence of vanishing bile duct syndrome - expression of a paraneoplastic syndrome, hemophagocytic lymphohistiocytosis, peliosis hepatis or association of lymphoma with infection with hepatitis viruses or human immunodeficiency virus or different autoimmune diseases. This review summarizes the clinical experience acquired on the relationship between Hodgkin's lymphoma and liver, …

Hepatitismedicine.medical_specialtyPathologyChemotherapyHemophagocytic lymphohistiocytosisbusiness.industrymedicine.medical_treatmentVanishing bile duct syndromeJaundicemedicine.diseaseHodgkin's lymphomaGastroenterology03 medical and health sciences0302 clinical medicineimmune system diseaseshemic and lymphatic diseases030220 oncology & carcinogenesisInternal medicinemedicine030211 gastroenterology & hepatologyPeliosis hepatismedicine.symptomLiver dysfunctionbusinessInternational Journal of Pharmacology, Phytochemistry and Ethnomedicine
researchProduct

Letter: liver dysfunction and survival in hepatocellular carcinoma treated by transarterial chemoembolisation - authors’ reply

2012

medicine.medical_specialtyHepatologybusiness.industryGeneral surgeryGastroenterologymedicine.diseaseGastroenterologyInternal medicineHepatocellular carcinomahepatocellular carcinoma transarterial chemoembolisationmedicinePharmacology (medical)Liver dysfunctionbusinessAlimentary Pharmacology & Therapeutics
researchProduct

Eine 22-jährige Mutter mit starkem Juckreiz und zunehmendem Ikterus zwei Wochen nach Beginn der hormonalen Kontrazeption

2016

Eine intermittierend auftretende cholestatische Lebererkrankung kann einen angeborenen Defekt im Bereich der Gallensaurentransportproteine offenlegen. Die Episoden konnen durch eine Schwangerschaft oder die Einnahme oraler Kontrazeptiva oder anderer Medikamente ausgelost werden. Wir beschreiben den Fall einer 22-jahrigen Mutter, bei der zwei Wochen nach Beginn der hormonalen Kontrazeption ein zunehmender Ikterus und schwerer Juckreiz auftrat. Bereits einige Monate zuvor hatte sie an Juckreiz im Rahmen einer intrahepatischen Schwangerschaftscholestase gelitten. Die Leberbiopsie zeigte eine Cholestase in unauffalligem Lebergewebe. Die Behandlung mit Ursodesoxycholsaure war nicht erfolgreich. …

Gynecologymedicine.medical_specialtyeducation.field_of_studyPediatricsbusiness.industryFamily characteristicsDisease progressionPopulationGastroenterologySigns and symptomsJaundicemedicine.disease03 medical and health sciencesHealth services0302 clinical medicine030220 oncology & carcinogenesismedicine030211 gastroenterology & hepatologymedicine.symptomLiver dysfunctioneducationbusinessCholestatic pruritusZeitschrift für Gastroenterologie
researchProduct

Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19)

2020

Abstract Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory disease, which can evolve into multi-organ failure (MOF), leading to death. Several biochemical alterations have been described in COVID-19 patients. To date, many biomarkers reflecting the main pathophysiological characteristics of the disease have been identified and associated with the risk of developing severe disease. Lymphopenia represents the hallmark of the disease, and it can be detected since the early stage of infection. Increased levels of several inflammatory biomarkers, including c-reactive protein, have been found in COVID-19 patients and associ…

Kidney DiseaseClinical BiochemistryMyocardial InfarctionMedicine (miscellaneous)Disease030204 cardiovascular system & hematologySeverity of Illness Index0302 clinical medicineBiomarkers Coronavirus Infection030212 general & internal medicinebiochemical alterationAged 80 and overHealth PolicyLiver DiseasesMusclesLiver DiseaseRespiratory diseaseBlood Coagulation DisordersWater-Electrolyte BalancePathophysiologyC-Reactive ProteinDisease ProgressionCytokinesbiomarkerMuscleKidney DiseasesLiver dysfunctionCoronavirus InfectionsHumanCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia Viralmacromolecular substances03 medical and health sciencesBetacoronavirusLymphopeniamedicineHumansCytokinePandemicsAgedInflammationBlood Coagulation DisorderBetacoronavirubusiness.industrySARS-CoV-2Biochemistry (medical)Public Health Environmental and Occupational HealthCOVID-19Biochemical biomarkersmedicine.diseaseImmunologyCytokine stormbusinesslaboratoryBiomarkers
researchProduct

Adipose tissue in obesity and obstructive sleep apnoea

2011

A European Respiratory Society research seminar on ‘‘Metabolic alterations in obstructive sleep apnoea (OSA)’’ was jointly organised in October 2009 together with two EU COST actions (Cardiovascular risk in the obstructive sleep apnoea syndrome, action B26, and Adipose tissue and the metabolic syndrome, action BM0602) in order to discuss the interactions between obesity and OSA. Such interactions can be particularly significant in the pathogenesis of metabolic abnormalities and in increased cardiovascular risk in OSA patients. However, studying the respective role of OSA and obesity is difficult in patients, making it necessary to refer to animal models or in vitro systems. Since most OSA p…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyLipoxygenaseAdipose tissueMiceInsulin resistancestomatognathic systemAnimalsHumansMedicineObesityHypoxiaIntensive care medicineDyslipidemiasInflammationSleep Apnea Obstructivebusiness.industryAdipocyte dyslipidaemia hypoxia liver dysfunction obesitySleep apneaHypoxia (medical)medicine.diseaseObesitySleep in non-human animalsRatsnervous system diseasesrespiratory tract diseasesOxidative StressAdipose TissuePhysical therapyFemaleInsulin ResistanceLiver dysfunctionMetabolic syndromemedicine.symptombusinessEuropean Respiratory Journal
researchProduct

Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications

2021

Simple Summary This review proposes a comprehensive overview of the main prognostic systems for HCC classified as prognostic scores, staging systems, or combined systems. Prognostic systems for HCC are usually compared in terms of homogeneity, monotonicity of gradients, and discrimination ability. However, despite the great number of published studies comparing HCC prognostic systems, it is rather difficult to identify a system that could be universally accepted as the best prognostic scheme for all HCC patients encountered in clinical practice. In order to give a contribute in this topic, we conducted a study aimed at externally validate the MESH score and the CNLC classification using the…

Cancer Researchmedicine.medical_specialtyReviewlcsh:RC254-282Prognostic score03 medical and health sciences0302 clinical medicinemedicineIn patientMedical physicsStaging systemmonotonicity of gradientsSettore MED/12 - Gastroenterologiadiscrimination ability; hepatocellular carcinoma; homogeneity; monotonicity of gradients; prognostic performance; prognostic systembusiness.industryprognostic systemExternal validationMono-tonicity of gradienthepatocellular carcinomamedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensSettore MED/18homogeneityOncology030220 oncology & carcinogenesisHepatocellular carcinomaPopulation data030211 gastroenterology & hepatologyGeneral healthdiscrimination abilityLiver dysfunctionbusinessprognostic performanceCancers
researchProduct

Beyond cure

2015

PURPOSE OF REVIEW The aim of this review was to define the implication of hepatitis C virus (HCV) eradication in patients with cirrhosis. RECENT FINDINGS Sustained virologic response (SVR) is associated with a favourable outcome in patients with cirrhosis especially in the presence of regression of cirrhosis but also with extrahepatic outcomes regarding health-related quality of life, risk of diabetes, risk of cardiovascular diseases and control of HIV replication by antiretroviral therapy. In patients with decompensated cirrhosis identifying the point of no return where viral eradication is not followed by clinical improvement is extremely relevant. A strict follow-up is needed in order to…

Liver Cirrhosismedicine.medical_specialtyCirrhosisHepatitis C virusImmunologymacromolecular substancesmedicine.disease_causeGastroenterologyEnd Stage Liver DiseaseQuality of lifeVirologyDiabetes mellitusInternal medicinemedicineHumansIn patientIntensive care medicineOncology (nursing)business.industryvirus diseasesEnd stage liver diseaseHematologyHepatitis C Chronicmedicine.diseasedigestive system diseasesInfectious DiseasesOncologyVirologic responseLiver dysfunctionbusinessCurrent Opinion in HIV and AIDS
researchProduct